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INTRODUCTION: Current preclinical tests 
utilize a combination of monolayer cultures and 
animal models to assess biocompatibility
1
. This is 
despite ethical considerations, a lack of cross- 
species translation, cost and non-relevant structural 
and biochemical pathways. Therefore, a relevant 
tissue engineered (TE) model of the 
musculoskeletal system is proposed (MSk). In 
order to create a relevant 3D TE preclinical MSk 
testbed, each component (skeletal muscle and bone 
constructs) must first be capable of simultaneous 
culture in a single contiguous system. This work 
presents conditions for the successful co-culture of 
3D tissue engineered skeletal muscle and bone 
models. 
METHODS: C2C12 murine muscle precursor 
cells (MPC) and TE85 human osteosarcoma cells 
were seeded within type-1 rat-tail collagen 
(2.20mg/mL) and collagen/nano-hydroxyapatite 
constructs respectively. Nano-hydroxyapatite 
(nHA) was precipitated through the reaction of 
calcium acetate and ammonium phosphate tribasic 
solutions. After removal of unbound water, the 
nHA was mixed with the collagen prior to cell 
seeding. Skeletal muscle (C2C12) constructs 
(SkM) were tethered at either end by bespoke 
polythene mesh floatation bars to facilitate 
alignment of MPC’s and subsequent differentiation 
into myotubes. Bone (TE85) constructs (B) were 
set within a bespoke circular mould and restrained 
by a centrally located pin and bead. Both  
constructs were placed in 20% FBS high glucose 
DMEM for 4 days and then cultured in 2% horse 
serum high glucose DMEM for a further 10 days; 
these being the standard conditions to induce MPC 
differentiation. 
RESULTS: Both SkM and B constructs reduced  
in width and diameter over the 14 day time-course, 
indicating successful cell attachment and 
remodelling. Immunohistochemical analysis 
showed successful myotube formation within the 
skeletal muscle construct and a randomly 
orientated, osteocyte-like morphology with clear 
cell protuberances within the bone model. 
DISCUSSION  &  CONCLUSIONS:   This work 
demonstrates the successful simultaneous co- 
culture of tissue engineered skeletal muscle and 
bone within a single system. This data shows 
conservation of previously reported morphological 
observations of a collagen-based skeletal muscle 
construct 
2, 3 
without obvious negative effects from 
the adjacent bone culture. The bone construct 
similarly showed no deviation from expected 
observations and therefore shows potential for 
muscle and bone co-culture within a contiguous 
construct. 
Fig. 1: (Top) Collagen based skeletal muscle and 
bone constructs cultured in a single well for 14 
days. (Bottom Left) 40x mag. Parallel alignment of 
C2C12 myotube structures within skeletal muscle 
construct. (Bottom Right) 40x mag. Randomly 
aligned osteocyte-like morphology of TE85s within 
collagen scaffold. Immunohistochimistry: 
Phalloidin (actin) - Red; DAPI (nuclei) – Blue. 
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